Literature DB >> 31316766

Does the Liver Provide Immunosuppressive Advantage?

Josh Levitsky1.   

Abstract

Year:  2019        PMID： 31316766      PMCID： PMC6605736          DOI： 10.1002/cld.817

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  3 in total

1.  Impact of COVID-19 Infection on Liver Transplant Recipients: Does It Make Any Difference?

Authors:  Daniela Punga; Sebastian Isac; Cristian Paraipan; Mihail Cotorogea; Andreea Stefan; Cristian Cobilinschi; Ileana Adela Vacaroiu; Raluca Tulin; Dorin Ionescu; Gabriela Droc
Journal:  Cureus       Date:  2022-02-28

2.  The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors.

Authors:  Lilong Zhang; Chen Chen; Dongqi Chai; Chunlei Li; Yongjun Guan; Li Liu; Tianrui Kuang; Wenhong Deng; Weixing Wang
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

3.  Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients.

Authors:  F Boix; I Legaz; A Minhas; R Alfaro; V Jiménez-Coll; A Mrowiec; H Martínez-Banaclocha; J A Galián; C Botella; M R Moya-Quiles; F Sanchez-Bueno; R Robles; J de la Peña-Moral; P Ramirez; J A Pons; A Minguela; M Muro
Journal:  Clin Exp Immunol       Date:  2020-10-29       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.